Mathenjwa, T. http://orcid.org/0000-0003-2436-9972
Kim, H.-Y.
Zuma, T.
Shahmanesh, M.
Seeley, J.
Matthews, P.
Wyke, S.
McGrath, N.
Sartorius, B.
Yapa, H. M.
Adeagbo, O.
Blandford, A.
Dobra, A.
Bäernighausen, T.
Tanser, F.
Funding for this research was provided by:
National Institutes of Health (R01- AI124389)
Article History
Received: 19 June 2019
Accepted: 3 July 2019
First Online: 19 July 2019
Ethics approval and consent to participate
: The trial is being conducted with the Africa Health Research Institute’s ongoing population-based HIV testing platform which received approval by the Biomedical Research Ethics Committee of the University of KwaZulu-Natal (BE290/16). Additional ethical approval specific to the HITS intervention was received on 28 June 2017(BFC398/16). The trial is being conducted with permission from the KwaZulu-Natal Department of Health, South Africa. Written informed consent is sought from individuals aged 18+ and parental/guardian consent with child assent for individuals 15–17 years old.Whilst this is deemed a low risk study, a Steering Committee was appointed to provide trial oversight and meet once a year to review study progress, adherence to the protocol and safety of study participants. Any study related adverse events will be documented and reported to the Steering Committee. The Steering Committee members are investigators and experts in HIV program, epidemiology and statistics.
: Not applicable.
: The authors declare that they have no competing interests.